{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:00:57Z","timestamp":1786114857782,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92159304"],"award-info":[{"award-number":["92159304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373823"],"award-info":[{"award-number":["82373823"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930099"],"award-info":[{"award-number":["81930099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130102"],"award-info":[{"award-number":["82130102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20230104"],"award-info":[{"award-number":["BK20230104"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20212011"],"award-info":[{"award-number":["BK20212011"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Zhonghua renmin gongheguo kexue jishu bu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2019ZX09301163"],"award-info":[{"award-number":["2019ZX09301163"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011360","name":"State Key Laboratory of Natural Medicines","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xcrm.2026.102868","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:01:06Z","timestamp":1781276466000},"page":"102868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-genetically reprogrammed meta-neutrophils potentiate chemo-immunotherapy against lung metastatic triple-negative breast cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Meixi","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caoyun","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102868_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric Antigen Receptor Therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102868_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41571-024-00959-y","article-title":"Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks","volume":"22","author":"Diorio","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102868_bib3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","article-title":"CAR-T therapy in solid tumors","volume":"43","author":"Du","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102868_bib4","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.immuni.2021.07.012","article-title":"Autophagy modulates endothelial junctions to restrain neutrophil diapedesis during inflammation","volume":"54","author":"Reglero-Real","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102868_bib5","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2020.10.003","article-title":"Co-option of Neutrophil Fates by Tissue Environments","volume":"183","author":"Ballesteros","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102868_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114380","article-title":"An EPR-Independent extravasation Strategy: Deformable leukocytes as vehicles for improved solid tumor therapy","volume":"187","author":"Wu","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2026.102868_bib7","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.cell.2021.04.016","article-title":"Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis","volume":"184","author":"Cui","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102868_bib8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102868_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102868_bib10","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1158\/0008-5472.CAN-23-0193","article-title":"Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer","volume":"83","author":"Chen","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102868_bib11","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.4049\/jimmunol.175.11.7678","article-title":"T cell-regulated neutrophilic inflammation in autoinflammatory diseases","volume":"175","author":"Keller","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102868_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2017.e00438","article-title":"Young donor white blood cell immunotherapy induces extensive tumor necrosis in advanced-stage solid tumors","volume":"3","author":"Maharaj","year":"2017","journal-title":"Heliyon"},{"key":"10.1016\/j.xcrm.2026.102868_bib13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cac2.70027","article-title":"Neutrophils in cancer: At the crucial crossroads of anti-tumor and pro-tumor","volume":"45","author":"Cai","year":"2025","journal-title":"Cancer Commun."},{"key":"10.1016\/j.xcrm.2026.102868_bib14","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","article-title":"Neutrophil profiling illuminates anti-tumor antigen-presenting potency","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102868_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.immuni.2018.02.002","article-title":"Developmental Analysis of Bone Marrow Neutrophils Reveals Populations Specialized in Expansion, Trafficking, and Effector Functions","volume":"48","author":"Evrard","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102868_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of Tumor-Associated Neutrophil Phenotype by TGF-\u03b2: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102868_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGF\u03b2","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102868_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2021.06.012","article-title":"Simultaneous blockage of contextual TGF-\u03b2 by cyto-pharmaceuticals to suppress breast cancer metastasis","volume":"336","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.xcrm.2026.102868_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2567.2004.01849.x","article-title":"Interferon-\u03b3 activation of polymorphonuclear neutrophil function","volume":"112","author":"Ellis","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.xcrm.2026.102868_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102868_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn3257","article-title":"IFN-\u03b3 primes bone marrow neutrophils to acquire regulatory functions in severe viral respiratory infections","volume":"10","author":"Creusat","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.102868_bib22","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.cell.2023.02.032","article-title":"A neutrophil response linked to tumor control in immunotherapy","volume":"186","author":"Gungabeesoon","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102868_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2022.04.007","article-title":"Neutrophils-typical atypical antigen presenting cells?","volume":"247","author":"Polak","year":"2022","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.xcrm.2026.102868_bib24","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41586-025-09012-z","article-title":"Interferon-\u03b3 orchestrates leptomeningeal anti-tumour response","volume":"643","author":"Remsik","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102868_bib25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102868_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1470-2045(19)30689-8","article-title":"Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"21","author":"Schmid","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102868_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-025-01237-3","article-title":"Shaping neutrophil morphology and function: the importance of a segmented nucleus","volume":"26","author":"van Grinsven","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102868_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307389120","article-title":"Vimentin regulates nuclear segmentation in neutrophils","volume":"120","author":"Liu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102868_bib29","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine Expression in Melanoma Metastases Associated with CD8(+) T-Cell Recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102868_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ccell.2016.06.001","article-title":"Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer","volume":"30","author":"Singhal","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102868_bib31","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s41590-018-0229-5","article-title":"Unique pattern of neutrophil migration and function during tumor progression","volume":"19","author":"Patel","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.102868_bib32","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.celrep.2014.12.039","article-title":"Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer","volume":"10","author":"Sagiv","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102868_bib33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41575-021-00568-5","article-title":"Neutrophils as potential therapeutic targets in hepatocellular carcinoma","volume":"19","author":"Geh","year":"2022","journal-title":"Nat. Rev. Gastro. Hepat."},{"key":"10.1016\/j.xcrm.2026.102868_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature16140","article-title":"Neutrophils support lung colonization of metastasis-initiating breast cancer cells","volume":"528","author":"Wculek","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102868_bib35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature14282","article-title":"IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102868_bib36","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1158\/0008-5472.CAN-07-5644","article-title":"Subtypes of breast cancer show preferential site of relapse","volume":"68","author":"Smid","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102868_bib37","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.4049\/jimmunol.181.10.7121","article-title":"A novel role for neutrophils as critical activators of NK cells","volume":"181","author":"Sp\u00f6rri","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102868_bib38","doi-asserted-by":"crossref","first-page":"12621","DOI":"10.18632\/oncotarget.2181","article-title":"Neutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells","volume":"5","author":"Sun","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2026.102868_bib39","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41573-025-01210-8","article-title":"Targeting neutrophils for cancer therapy","volume":"24","author":"Kwak","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102868_bib40","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41573-021-00285-3","article-title":"Engineering living therapeutics with synthetic biology","volume":"20","author":"Cubillos-Ruiz","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102868_bib41","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/s41590-019-0476-0","article-title":"At the end of the beginning: immunotherapies as living drugs (vol 20, pg 955, 2019)","volume":"20","author":"Feigal","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.102868_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jconrel.2020.08.063","article-title":"Cytopharmaceuticals: An emerging paradigm for drug delivery","volume":"328","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.xcrm.2026.102868_bib43","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.xcrm.2026.102868_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201804191","article-title":"Neoadjuvant Chemotherapy Based on Abraxane\/Human Neutrophils Cytopharmaceuticals with Radiotherapy for Gastric Cancer","volume":"15","author":"Ju","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.xcrm.2026.102868_bib45","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jconrel.2023.05.037","article-title":"New-generation cytopharmaceuticals with powerfully boosted extravasation for enhanced cancer therapy","volume":"359","author":"Zhang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.xcrm.2026.102868_bib46","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1200\/JCO.2015.64.8931","article-title":"Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study","volume":"34","author":"Nanda","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102868_bib47","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","article-title":"Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial","volume":"25","author":"Voorwerk","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102868_bib48","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nm.3391","article-title":"Tumor metastasis: moving new biological insights into the clinic","volume":"19","author":"Wan","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102868_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3180","article-title":"Treating metastatic cancer with nanotechnology","volume":"12","author":"Schroeder","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102868_bib50","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","article-title":"CAR T therapy beyond cancer: the evolution of a living drug","volume":"619","author":"Baker","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102868_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6667","article-title":"Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy","volume":"12","author":"Hao","year":"2020","journal-title":"Sci. Transl. Med."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T22:12:42Z","timestamp":1785967962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126002855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666379126002855"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102868","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-genetically reprogrammed meta-neutrophils potentiate chemo-immunotherapy against lung metastatic triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102868","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102868"}}